首页> 外文期刊>Experimental & Molecular Pathology >Automated processing of fluorescence in-situ hybridization slides for HER2 testing in breast and gastro-esophageal carcinomas
【24h】

Automated processing of fluorescence in-situ hybridization slides for HER2 testing in breast and gastro-esophageal carcinomas

机译:荧光原位杂交玻片的自动化处理,用于乳腺癌和食管癌中的HER2检测

获取原文
获取原文并翻译 | 示例
       

摘要

Background: HER2 fluorescence in-situ hybridization (FISH) is used in breast and gastro-esophageal carcinoma for determining HER2 gene amplification and patients' eligibility for HER2 targeted therapeutics. Traditional manual processing of the FISH slides is labor intensive because of multiple steps that require hands on manipulation of the slides and specifically timed intervals between steps. This highly manual processing also introduces inter-run and inter-operator variability that may affect the quality of the FISH result. Therefore, we sought to incorporate an automated processing instrument into our FISH workflow. Methods: Twenty-six cases including breast (20) and gastro-esophageal (6) cancer comprising 23 biopsies and three excision specimens were tested for HER2 FISH (Pathvysion, Abbott) using the Thermobrite Elite (TBE) system (Leica). Up to 12 slides can be run simultaneously. All cases were previously tested by the Pathvysion HER2 FISH assay with manual preparation. Twenty cells were counted by two observers for each case; five cases were tested on three separate runs by different operators to evaluate the precision and inter-operator variability. Results: There was 100% concordance in the scoring between the manual and TBE methods as well as among the five cases that were tested on three runs. Only one case failed due to poor probe hybridization. In total, seven cases were positive for HER2 amplification (HER2:CEP17 ratio >. 2.2) and the remaining 19 were negative (HER2:CEP17 ratio < 1.8) utilizing the 2007 ASCO/CAP scoring criteria. Due to the automated denaturation and hybridization, for each run, there was a reduction in labor of 3.5. h which could then be dedicated to other lab functions. Conclusion: The TBE is a walk away pre- and post-hybridization system that automates FISH slide processing, improves work flow and consistency and saves approximately 3.5. h of technologist time. The instrument has a small footprint thus occupying minimal counter space. TBE processed slides performed exceptionally well in comparison to the manual technique with no disagreement in HER2 amplification status.
机译:背景:HER2荧光原位杂交(FISH)用于乳腺癌和食管癌,以确定HER2基因扩增和患者是否适合HER2靶向治疗。 FISH载玻片的传统手动处理是劳动密集型的,因为需要多个步骤才能动手操作载玻片,并且各步骤之间需要特别的时间间隔。这种高度手动的处理还引入了运行间和操作员间的可变性,这可能会影响FISH结果的质量。因此,我们寻求将自动化处理工具整合到我们的FISH工作流程中。方法:使用Thermobrite Elite(TBE)系统(Leica)对包括23例活检和3例切除标本在内的26例乳腺癌(20例)和胃食管癌(6例)进行了HER2 FISH(Pathvysion,Abbott)测试。最多可以同时运行12张幻灯片。所有病例之前均已通过Pathvysion HER2 FISH分析和人工准备进行了检测。每个病例由两名观察员计数二十个牢房。由不同的操作员在三个单独的运行中测试了5个案例,以评估精度和操作员间的变异性。结果:手动和TBE方法之间的评分以及在三轮运行中测试的五种情况之间的评分均保持100%的一致性。由于探针杂交不良,只有一例失败。根据2007年ASCO / CAP评分标准,总共有7例HER2扩增阳性(HER2:CEP17比>。2.2),其余19例阴性(HER2:CEP17比<1.8)。由于自动变性和杂交,每次运行的人工减少了3.5。 h然后可以专门用于其他实验室功能。结论:TBE是一个无需走动的杂交前和杂交后系统,可自动进行FISH玻片加工,改善工作流程和一致性,并节省约3.5倍。技术人员时间h。该仪器占地面积小,因此占用的计数器空间最小。与手工技术相比,TBE处理过的玻片表现出色,并且在HER2扩增状态上没有分歧。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号